{
  "name" : "dacemirror.sci-hub.se_journal-article_17faaefb4e4a3db868d0abb2fb54e3af_alibolandi2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery",
    "authors" : [ "Mona Alibolandi", "Marzieh Mohammadi Seyed", "Mohammad Taghdisi Heidarian", "Mohammad Ramezani", "Marzieh Mohammadi", "Khalil Abnous" ],
    "emails" : [ "ramezanim@mums.ac.ir", "abnouskh@mums.ac.ir" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nTitle: Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery Author: Mona Alibolandi Marzieh Mohammadi Seyed Mohammad Taghdisi Heidarian Mohammad Ramezani Prof. Khalil Abnous Prof. PII: S0144-8617(16)30981-X DOI: http://dx.doi.org/doi:10.1016/j.carbpol.2016.08.046 Reference: CARP 11471 To appear in: Received date: 30-6-2016 Revised date: 4-8-2016 Accepted date: 15-8-2016 Please cite this article as: Alibolandi, Mona., Mohammadi, Marzieh., Heidarian, Seyed Mohammad Taghdisi., Ramezani, Mohammad., & Abnous, Khalil., Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery.Carbohydrate Polymers http://dx.doi.org/10.1016/j.carbpol.2016.08.046 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\n1 | P a g e\nFabrication of aptamer decorated dextran coated nano-graphene oxide for\ntargeted drug delivery\nMona Alibolandi1¥, Marzieh Mohammadi2¥, Seyed Mohammad Taghdisi Heidarian3,\nMohammad Ramezani1,2*, Khalil Abnous1*\n1Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran 2Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran 3Targeted Drug Delivery Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran\n¥ These authors contributed equally to this work.\n*Corresponding authors: Prof. Mohammad Ramezani, Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Tel/Fax: +98 51 37112470, E-mail: ramezanim@mums.ac.ir Prof. Khalil Abnous, Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Tel/Fax: +98 51 38823255, E-mail: abnouskh@mums.ac.ir\n2 | P a g e"
    }, {
      "heading" : "Highlights",
      "text" : " Dextran (DEX) was covalently conjugated to the surface of GO sheets.\n Biocompatible dextran coated nano-GO (GO-DEX) was prepared.\n AS1411 aptamer has been introduced to hydroxyl groups of DEX in GO-DEX.\n Curcumin was loaded onto the GO-DEX and GO-DEX-Apt via π-π stacking\ninteractions.\n The GO-DEX-Apt-CUR nano-complex showed significantly higher cytotoxicity."
    }, {
      "heading" : "Abstract",
      "text" : "In the current study, dextran (DEX) was covalently conjugated to the surface of nano-GO sheets, making stable biocompatible dextran coated GO (GO-DEX). The prepared GO-DEX was nontoxic to 4T1 mammary carcinoma cell line at concentrations up to 300 µg/mL. AS1411 aptamer, a ssDNA aptamer which can improve the intracellular uptake by nucleolin recognition, also has been introduced to hydroxyl groups of DEX in GO-DEX to produce GO-DEX-Apt. Moreover, curcumin (CUR), a natural polyphenol, found in the rhizomes of Curcuma longa (turmeric) which shows antineoplastic effects, was loaded onto the GO-DEX and GO-DEX-Apt via π-π stacking interactions with a high loading capacity (~ 29 wt%). The GO-DEX-Apt-CUR could efficiently enter into 4T1 and MCF-7 nucleolin over-expressed cancer cells confirmed by fluorescence microscope and flowcytometry, and it also showed significantly higher cytotoxicity. These types of targeted nanoscale drug delivery vehicles on the basis of DEX coated GO may find potential application in cancer chemotherapy.\nKeywords: Graphene oxide; Dextran; AS1411; Curcumin\n3 | P a g e\n1. Introduction\nNanoparticle-based drug delivery systems for enhancing the therapeutic efficiency of chemotherapeutics are the hot spot of research in the field of nanobiotechnology(L. Zhang, Xia, Zhao, Liu, & Zhang, 2010). To date different drug delivery vehicles have been introduced including dendrimers (W. Hu et al., 2016), liposomes (Espelin, Leonard, Geretti, Wickham, & Hendriks, 2016), polymerosomes (X. Liu, Yaszemski, & Lu, 2016) and inorganic nanomaterials such as gold nanoparticles (Tsai, Hsieh, Lu, Wang, & Mi, 2016) mesoporous silica (Hakeem et al., 2016) or carbonaceous materials (Panczyk, Wolski, & Lajtar, 2016). Although there are many advantages associated with these nanoparticles such as increasing the solubility of hydrophobic drugs or higher bioavailability (Lu, Wu, Yin, Zhang, & Cai, 2014), there are still a number of drawbacks such as burst release, limited stability of formulations leading to drug leakage and nonspecific cellular uptake resulting in undesired adverse effects(Hu & Zhang, 2009). Recently, graphene-based materials have received tremendous attention as drug delivery vehicles (S. Zhang, Yang, Feng, & Liu, 2011). Graphene is a novel carbon material with one atom thick two dimensional layers. However, due to strong graphene-graphene interactions, graphene is poorly soluble in aqueous solutions (Maity, Chakraborty, Mondal, & Jana, 2014). Graphene oxide (GO) is the oxidized derivative of graphene which has been explored extensively in biological applications such as controlled drug delivery, nanocomposites and gene delivery (S. Zhang et al., 2011). Recent studies demonstrated that GO and derivatives are not only used as drug delivery platforms but also act as hyperthermia agent in photothermal therapy to elevate the cytotoxicity of antineoplastic agents in lower doses or to regulate the drug release profile (Li et al., 2015; Mauro, Scialabba, Cavallaro, Licciardi, & Giammona, 2015). Besides, due to its unique electronic, mechanical and thermal properties\n4 | P a g e\nand good near-infrared (NIR) absorbance, GO has attracted considerable attention in developing biosensors and imaging contrast agents (Yang et al., 2016; C. Zhang, Yuan, Zhang, Wang, & Liu, 2011). High surface area and the presence of functional moieties such as hydroxyl, carboxyl, epoxy groups which allow the attachment of targeting agents and drug molecules, made GO an attractive material in biomedical studies. It was claimed that aromatic ring-containing anticancer drugs such as curcumin (CUR) and camptothecin (CPT) could be loaded on graphene-based materials with high efficiency (Z. Liu, Robinson, Sun, & Dai, 2008). Although GO is dispersed more easily in water than graphene, it would aggregate in salt-rich solutions and cell medium or serum. Furthermore, studies claimed that GO and graphene exhibited certain cellular toxicity to cell cultures in vitro and animal cells in vivo (S. Zhang et al., 2011). However, GO which is coated by biocompatible polymers such as polyethylene glycol (PEG) or DEX does not seem to be toxic in the tested doses (S. Zhang et al., 2011), it is highly aqueous dispersible and stable in biological fluids compared to GO (Z. Liu et al., 2008). Dextran is a natural, hydrophilic homopolysacharide of glucose with unique favourable properties such as biodegradability, hydrophilicity and superior colloidal stability (Z. Zhang et al., 2013). Studies demonstrated that DEX coated nanoparticles are more colloidal stable than those coated with PEG chains (Goodwin et al., 2008). Meanwhile, DEX has more reactive sites compared to PEG. The hydroxyl groups of DEX can be modified to react with various functional groups. Also, DEX-coated nanoparticles are less prone to non-specific protein adsorption(Xie et al., 2016; S. Zhang et al., 2011). There are many studies exploring the efficiency of electrostatic loading of aromatic, water insoluble anticancer drugs on nanographene oxide (S. Zhang et al., 2011) In this regard, CUR is a naturally occurring polyphenol which is the main component of Curcuma longa and it is found to have wide range of medicinal properties(Aggarwal & Sung,\n5 | P a g e\n2009). Many studies proved its antimicrobial(Barua et al., 2014), anti-inflammatory (Hatamie et al., 2015) and anticancer effects (Some et al., 2014). The anticancer properties of CUR are due to the down-regulation of different transcription factors such as NF-kB, AP-1 and betacatenin (Pillai et al., 2015). However, the therapeutic use of CUR is limited due to the low solubility, high clearance rate and low bioavailability leading to suboptimal blood concentrations (Naksuriya, Okonogi, Schiffelers, & Hennink, 2014). To enhance the poor biopharmaceutical properties of CUR and improve the aqueous solubility, we loaded CUR via noncovalent physisorption on to the surface of graphene oxide-dextran nano-hybrid (GODEX). Recently, it was demonstrated that targeted delivery of nanomedicine could be a promising approach to specifically deliver the drug to the target cell population and reduce the undesired effects associated with anticancer agents (Gao et al., 2012). Nucleolin is 76 kDa transmembrane glycoprotein highly expressed in the plasma membrane of tumor cells comprising DU145 (prostate cancer cell line), MDA-MB-231, MCF-7 (breast cancer cell lines) and 4T1 ( murine metastatic breast cancer cell) (L. Li et al., 2014), A549 (lung cancer cell line), and HeLa (cervical cancer cell line)(Alibolandi, Ramezani, Abnous, & Hadizadeh, 2016). Accumulating evidences validated that cell surface nucleolin acted together with protein complexes associated with tumorgenesis and angiogenesis suggesting that nanoparticle-conjugated aptamer could enhance the cellular uptake and the efficiency of the drug delivery while reducing the side effects associated with the cytotoxic drugs (Koutsioumpa & Papadimitriou, 2014; Malik et al., 2015). In order to increase the cellular uptake and improve the drug delivery efficiency, AS1411 aptamer was covalently attached to our newly designed nanoparticle composed of DEX coated nano-GO. Until now, the targeted delivery of CUR using GO-DEX-AS1411 aptamer nanocomplex to tumor cells is not reported in the literature. Thus, the main goal of the current\n6 | P a g e\nstudy is to enhance the delivery of CUR loaded GO-DEX-Apt to the nucleolin overexpressed 4T1 and MCF-7 cells.\n2. Materials and methods 2.1. Materials\nGraphite powder was obtained from Loba Chemie (Delhi, India). All reagents and solvents were of analytical grade and obtained from commercially available suppliers (Merck AG and Sigma Aldrich) and used without further purification. CUR was purchased from Euroasian Chemicals Pvt. Ltd. (Delhi, India). Pharmaceutical grade DEX (MW 5000 Da) was procured from Pharmacosmos (Holbaek, Denmark). N-hydroxysulfosuccinimide (NHS), 1-ethyl3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 1,2-ethylenediamine (EDA), sodium cyanoborohydride (NaCNBH3) and carbonyl diimidazole (CDI) were purchased from Sigma-Aldrich (Schnelldorf, Germany). An ssDNA-aptamer for nucleolin reported previously was employed as the targeting ligand. The oligonucleotides were synthesized by Microsynth Co. Ltd. (Basel, Switzerland). The sequence of the modified aptamer was 5′-NH2-C6GGTGGTGGTGGTTGTGGTGGTGGTGG-3′.\n2.2.Graphene oxide (GO) Synthesis\nGraphene oxide was synthesized from graphite flake according to improved Hummers' method with some modifications (Marcano et al., 2010). Briefly, a 9:1 mixture of concentrated H2SO4/H3PO4 (120:13.3 mL) was added to a mixture of graphite flakes (1 g) and KMnO4 (6 g). The reaction was then heated to 50°C and stirred for 18 h. The reaction was cooled to room temperature and poured onto ice (135 mL) with 30% H2O2 (10 mL). The mixture was then sifted through a metal sieve (400 µm).\n7 | P a g e\nThe filtrate was centrifuged (8000 rpm for 30 min), and the supernatant was poured out. The remaining solid material was then washed with HCl 0.1 N and in succession with double distilled water. The synthesized GO was freeze-dried overnight to obtain ready to use final product.\n2.3. Synthesis of 1,2-ethylenediamine-terminated dextran (EDA-DEX)\nWe aimed to prepare amine-terminated dextran in order to conjugate the terminal amine groups to the carboxylic (COOH) groups on the surface of GO through classical amide coupling. Then the 1,2-ethylenediamine (EDA) was introduced to the end of the dextran. The amine terminated dextran (EDA-DEX) was prepared according to our previous study implementing DEX-terminal reductive amination reaction with sodium cyanoborohydride (NaCNBH3) as reducing agent (Alibolandi, Alabdollah, et al., 2016). Briefly, 1 g DEX (5000 Da) and 1,2-ethylenediamine (10-fold molar excess over DEX) was dissolved in 10 mL DMSO and stirred (600 rpm) at 60°C for 7 days. Then NaCNBH3 (20 mg) was added to the reaction each day. Finally the reaction was cooled to room temperature, and the aminated-DEX was precipitated by addition of 20 mL methanol. The EDA-DEX was accurately purified by vacuum filtration and successive washing with methanol. The purified EDA-DEX was lyophilized and stored at -20ºC until use. 1H NMR spectra were recorded in DMSO-d6 at room temperature using a Bruker Avance 300 MHz NMR spectrometer (Rheinstetten, Germany) to verify DEX amination (Fig. S1).\n2.4. Synthesis of GO-DEX\nGO (100 mg) was first dispersed in double-distilled water followed by 3 h water bath sonication at 20-25ºC. Then EDA-DEX (200 mg) and EDC.HCl (80 mg) was added to GO suspension and the mixture was further sonicated at 20-25ºC for 15 min.\n8 | P a g e\nThe suspension was stirred vigorously at room temperature overnight. The reaction mixture was then centrifuged at 4000 rpm for 10 min and supernatant was dialyzed (MW cutoff = 12- 14 KDa) against double-distilled water (6 L) for 2 days to remove unbound DEX. The final GO-DEX product was freeze-dried for 48 h and stored at -20ºC until use.\n2.5. Synthesis of GO-DEX- Apt\nThe GO-DEX (100 mg) was first dispersed in anhydrous DMSO followed by 15 min water bath sonication at 20-25ºC. Then excess amount of CDI (60 mg) was added to the suspension and stirred vigorously for 30 min at 45 ºC under argon. Finally AS1411 aptamer (100 µL of 5µM stock solution) was added to the suspension and the mixture was further stirred (400 rpm) overnight at 37ºC. Final product was diluted in double distilled water and dialyzed (MW cut off = 12-14 KDa) against double-distilled water (6 L) for 1 days to remove DMSO and by products. The purified GODEX-Apt was freeze-dried for 48 h and stored at -20ºC until use.\n2.6. Structural Characterization\nFourier transform infrared (FTIR) spectra of graphite, GO, GO-DEX and Apt-GO-DEX in the form of KBr pellets were recorded using a Paragon 1000 (Perkin Elmer, USA) FT-IR.\nThe ultraviolet-visible (UV/Vis) absorptions were recorded by a Varian CARY 100 UV/Vis\nspectrophotometer (California, USA). 1H NMR spectra of GO-DEX and GO-DEX-Apt were recorded in D2O at room temperature using a Bruker Avance 300 MHz NMR spectrometer (Rheinstetten, Germany) to verify aptamer conjugation to GO-DEX. Field emission scanning electron microscopy (FE-SEM, Mira III FEG, TESCAN-UK, Ltd.) and energy-dispersive X-ray spectroscopy were performed using field emission scanning electron microscopy equipped with an energy-dispersive X-ray spectrometer operated at 10 kV. The sample for FE-SEM was prepared as follows:\n9 | P a g e\nThe sample solution in deionized water (1 mg/ml) was prepared and dehydrated on a stub of metal with adhesive and coated with 40 nm gold and then observed. An atomic force microscope (AFM, model: Nano Wizard®II NanoScience AFM, JPK Instruments Inc., Germany) was implemented to investigate morphology of GO and GODEX. The AFM sample was prepared as follows: After cleaning of microscope glass cover slips (24 × 24 mm2, Fisher Scientific, UK), the samples were diluted in deionized water, dispensed to the glass cover slips and dried at room temperature. Measurements were carried out in contact mode and CSC17 cantilevers (Mikromasch, Germany) were implemented. The degree of grafting of DEX onto the GO surface was calculated by thermogravimetric analysis (TGA). Thermogravimetric analysis was carried out under nitrogen atmosphere using a TGA instrument (model: TGA 50, Shimadzu, Japan) by heating the sample at a rate of 10ºC/min to 600°C.\n2.7.Preparation of GO-DEX-CUR and GO-DEX-Apt-CUR\nGO-DEX or GO-DEX-Apt (10 mg) was reconstituted in deionized water (10 ml) and sonicated for 15 min at 20-25ºC. Then CUR (4 mg) was dissolved in 2 mL acetone and added drop wise to the either GO-DEX or Apt-GO-DEX suspension. The mixture was stirred overnight at room temperature. Then, the resulted mixture was centrifuged (4000 rpm, 10 min) and the supernatant was collected and successively washed with deionized water using ultrafiltration to remove residual free CUR (15 min., 3,500 rpm, MWCO: 30 kDa) (Millipore, Hampshire, U.K.). The EE and DL capacity of CUR in GO-DEX were assessed indirectly. The free CUR was isolated after 10 min centrifugation of GO-DEX-Cur/Apt-GO-DEX-Cur at 4000 rpm for 10 min and subsequently dissolved in DMSO. Finally the exact amount of free CUR was determined spectrophotometrically at 420 nm. The EE (encapsulation efficiency) and DL (drug loading) of CUR loaded on GO-DEX and GO-DEX-Apt vehicles were calculated as follows:\n10 | P a g e\nEE (%) = Total amount of CUR ̶ FreeCUR in percipitant\nTotal amount of CUR × 100 (1)\nDL (%) = Total amount of CUR ̶ Free CUR in precipitatnt\nMass of Final formulation × 100 (2)\n2.8. Release Study\nIn vitro drug release profile of curcumin from drug GO-DEX-CUR (10 mg) or GO-DEXApt-CUR were done by direct dispersion method as reported previously(Anitha et al., 2011). In vitro drug release studies were done for a period of 48 h at two different pH 7.4 and 5.5 to mimic the normal and tumor tissues environment respectively. GO-DEX-CUR (10 mg) or GO-DEX-Apt-CUR (10 mg) complex were re-suspended in PBS pH 7.4 or citrate buffer pH 5.5 (20 mL) and shaked in a shaker incubator set at 60 rpm and 37°C. At different times (5, 20, 24 h, 48 h), formulations centrifuged at 1500 rpm for 5 min to precipitate the released insoluble CUR, leaving the loaded CUR on the GO-DEX or GO-DEX-Apt surface which remains in supernatant. The pellets were dissolved in 1 ml DMSO and amount of CUR released was quantified spectrophotometerically at a wavelength of 420 nm.\n2.9.Cellular viability assay\n4T1 amurine breast carcinoma and MCF-7/CHO cells were routinely cultured (Alibolandi et al., 2015d) in high glucose DMEM medium and RPMI 1640 respectively which supplemented with a 10% (v/v) heat-inactivated foetal bovine serum, 100 U/ml of penicillin and 100 mg/ml of streptomycin at 37°C in a humidified atmosphere (95%) containing 5% CO2 for 3 days. The cells were collected, seeded in a 96-well tissue culture plate at a density of 5×103 cells/well and allowed to adhere overnight. The next day, cells were treated with free CUR, GO-DEX-CUR and GO-DEX-Apt-CUR containing equivalent amounts of CUR, GO or GO-DEX (up to 500 µg/mL) in 100 µL of a complete medium with 10% FBS for 6 h.\n11 | P a g e\nThe medium was then removed, and the cells were washed with PBS. The cells were then treated with 100 µL of a fresh complete medium (DMEM with 10% FBS) and further incubated for 24 or 48 h at 37°C in a humidified incubator. After incubation for 24 or 48 hours at 37ºC in a humidified incubator, 20 µL of MTT (5 mg/mL in PBS) were added to each well and incubated for 4 h. Then, MTT solution was aspirated from the wells, and 150 µL of DMSO was added to each well. After 20 min of mixing, the absorbance was recorded on a microplate reader at a wavelength of 545 nm with a reference wavelength of 630 nm using an Infinite® 200 PRO multimode microplate reader (Tecan Group Ltd. Männedorf, Switzerland).\n2.10. Cellular uptake by Fluorescence Microscopy\nThe cellular uptake of GO-DEX-CUR, free CUR and GO-DEX-Apt-CUR by 4T1 and MCF7 was examined using Juli Smart Cell Analyzer (Baker and Baker Ruskinn, USA). The cells at a density of 5×104 per well were seeded on a 12-wells plates and allowed to adhere overnight. Next, the cells were incubated for 3 h with either GO-DEX-CUR or GODEX-Apt-CUR (CUR concentration: 50 µg/mL). After a 3 h of incubation, the cells were washed five times with cold PBS and 3 times with freeze cold acetone:methanol (50:50) to fix the cells and then analyzed by fluorescence microscopy. Moreover, to illustrate the selective targeting of AS1411 aptamer on the 4T1 and MCF-7 cells by GO-DEX-Apt-CUR, a competitive experiment was performed. In this regard, excessive amounts (2 μg/well) of free AS1411 aptamer were added to each well 30 min prior to the addition of GO-DEX-Apt-CUR (Alibolandi, Sadeghi, et al., 2015).\n2.11. Cellular uptake by Flow cytometry\n4T1 and MCF-7 cells were seeded in 12-well plates at 5×104 cells per well and cultured for 24 h. The following day, the cells were incubated for 3 h with either non-targeted or targeted\n12 | P a g e\nGO-DEX-CUR (CUR concentration: 50 µg/mL). Then, the culture medium was removed, and the cells were trypsinized and centrifuged at 1400 rpm for 10 min. Supernatants were removed and the pellet was washed three times with cold PBS. The cells were then suspended in a flow cytometry buffer (0.1% sodium azide and 2% FBS in PBS), and the intensity of the doxorubicin fluorescence in the cells was determined on a BD FACSCalibur equipped with 488 laser in the FL1 channel. The data was analyzed using WinDMI 2.9 analysis software. Moreover, to illustrate the selective targeting of AS1411 aptamer on the 4T1 and MCF-7 cells by GO-DEX-Apt-CUR, a competitive experiment was performed. In this regard, excessive amounts (2 μg/well) of free AS1411 aptamer were added to each well 30 min prior to the addition of GO-DEX-Apt-CUR (Alibolandi, Ramezani, et al., 2015).\n3. Results and discussion 3.1. Synthesis and characterization of GO, GO-DEX and GO-DEX-Apt In this study the nanoscale good quality graphene oxide sheets were prepared from graphite flakes using a modified Hummers’ method (Malik et al., 2015). Briefly, graphite flake was dispersed in a mixture of sulfuric acid and phosphoric acid stirred at 35ºC to enhance oxidation and intercalation. Addition of KMnO4 as oxidizing agent increased the oxidation efficiency, extended the oxidation yield and consequently produced uniformly oxidized graphene sheets. The products were washed with dilute acid and water to purify the final product. After sonication for 2 h, the resulting GO particles were mostly single layered (~ 1 nm in height) and < 600 nm in width (Fig. 1A, B) according to atomic force microscopy height profile (AFM) and DLS characterization (Fig. 1F) which is in agreement with previous study (Alibolandi, Hadizadeh, Vajhedin, Abnous, & Ramezani, 2015).\n13 | P a g e\nThe SEM image of GO clearly showed that the GO owned sheet like structure with crinkles, ultrathin features and rolled edges (Fig. 2A). The FT-IR spectrum of GO revealed the excellent oxidation of graphite which were identical to those reported previously (Loh, Bao, Eda, & Chhowalla, 2010). As shown in Fig. 3, existence of skeletal vibration of unoxidized graphene (C=C, 1580 cm−1), hydroxyl (OH, 3400 cm−1) and carbonyl (C=O, 1735 cm-1) vibrations verified the successful oxidization of graphite and GO preparation (Y. Xu, Bai, Lu, Li, & Shi, 2008). By introduction of ethylenediamine-DEX onto the carboxyl groups of GO, the DEX conjugated product (GO-DEX) was obtained. GO-DEX represented high solubility and stability in PBS pH 7.4 and PBS pH 7.4 containing 20% BSA after 1 month storage at room temperature, which is ideal for pharmaceutical applications as a versatile vehicle (Fig. 1 G). Before DEX grafting, GO suspensions instantly aggregated in PBS pH 7.4 and 20% BSA solution (Fig. 1 H). This phenomenon obviously revealed that the stability of GO in PBS pH 7.4 and 20% BSA solution certainly depended on the presence of grafted DEX, conjugated hydrophilic and biocompatible DEX would improve stability in PBS and 20% BSA solution. In this regard the sizes of GO-DEX suspension in PBS pH 7.4 and PBS pH 7.4 containing 20% BSA remained unchanged even after one month storage at room temperature (70.43±3.61 nm, PDI: 0.17) while the sizes of GO suspension in PBS pH 7.4 and PBS pH 7.4 containing 20% BSA increased significantly (3215±7.65 nm, PDI: 0.62 and 4126.3±10.51, PDI: 0.57 respectively). AFM images showed sheet sizes of 10-200 nm and mostly < 200 nm in GO-DEX conjugates (Fig. 1C, D), while the GO sheets were 200-600 nm in size (Fig. 1A, B). The smaller nanoscale dimension of the GO-DEX was originated from the extra sonication step involved in DEX conjugation process (Fig. 1E).\n14 | P a g e\nThe nanoscale dimension of the prepared carrier represents the advantage of passive tumortargeting through enhanced permeation and retention (EPR) effects, which enhance the therapeutic index of carried drug (Levacheva et al., 2014; Song et al., 2014; Yan et al., 2015). Previous studies have also verified that the dextran coated nanoparticles contributed to nanoparticle accumulation at the tumor site due to poor lymphatic drainage of shielded nanoparticles. IR spectrum of purified GO-DEX samples indicated a characteristic amide linkage stretching vibration (∼1650 cm−1) (Z. Liu et al., 2008),while the sharp peak of GO carbonyl at 1735 cm1 became weak which confirmed the grafting of DEX molecules onto GO sheets (Fig. 3A). The measured thickness of GO-DEX sheets slightly increased to 1.8-2 nm (Figure 1C, D) after the DEX conjugation to GO surface. The GO-DEX was also characterized by FE-SEM. It is evident that intact GO sheets displays an ultrathin sheets like structure with a smooth surface (Fig. 2 A, C). In contrast, after DEX attachment, the surface of nano-GO-DEX sheets becomes slightly bumpy as shown in Fig. 2 B, D. The ratio of conjugated DEX was calculated using TGA. Moreover, TGA could demonstrate the thermal stability of GO after DEX conjugation. Figure 3B shows TGA curves of GO and GO-DEX. It can be concluded that GO was thermally unstable, and it started to lose weight at 80-100oC due to the evaporation of stored water in the π-stacked structure in GO sheets. The weight loss of GO was significantly enhanced at 150-300ºC due to the pyrolysis of oxygen-containing groups. Coating of GO surface with biocompatible DEX polymer augmented the thermal stability of GO sheets and the mass loss of GO-DEX was started from 300-350oC, which was\n15 | P a g e\napproximately 200ºC higher that of GO. It was estimated that GO-DEX contained about 38.8 wt% of GO and 61.2 wt% of DEX. In the next step, a single strand DNA (ssDNA) aptamer, AS1411 (against nucleolin) was conjugated to the DEX molecules on the GO–DEX sheet in order to target specific cancer cells for selective cell internalization. The degree of aptamer introduction was easily optimized by CDI concentration, which activated OH groups in DEX. When the CDI concentration was 60 mg in the reaction mixture, ~90% of aptamer was conjugated to DEX molecules (Weber, 2005). On the other hand, TGA results demonstrated that the aptamer conjugation to GO-DEX structure would not change the thermal stability of the prepared composite (Figure 3B). Figure 3C represented 1HNMR spectra of GO-DEX and GO-DEX-Apt. The resonances at 10-11.5 ppm, corresponding to guanine imino protons of Gquartet structure, appeared in GODEX-Apt spectrum. Table 1 represented the results of EDX before and after of aptamer conjugation. It can be concluded from the table that the content of phosphorus and nitrogen was found to increase to 2.1 and 11.4 wt%, respectively after the aptamer conjugation in comparison with the value of 0% and 1.3wt% phosphorus and nitrogen, respectively before the aptamer conjugation, which obviously confirmed the presence of aptamer on the surface of GO-DEX sheets. In addition, it should be mentioned that the low nitrogen content in GO-DEX is related to amide linkage between DEX and GO sheets.\n3.2. Curcumin loading and release\nNext, we evaluated the potency of GO-DEX as nanoscale sheet-like vehicles to carry an hydrophobic drug curcumin (CUR), a natural polyphenol, found in the rhizomes of Curcuma longa (turmeric) which showed anticancer effect (Wang et al., 2016).\n16 | P a g e\nThe loading of CUR was performed by simple mixing of either GO-DEX or GO–DEX–Apt solution (in double distilled water) with CUR (in acetone) overnight, followed by centrifugation to remove free, unbound CUR. The loading of CUR on either GO-DEX or GO-DEX-Apt surface was visible from the yellowish colour of the GO–DEX-CUR or GODEX-Apt-CUR solutions due to loaded CUR and its characteristic UV-vis absorbance peak at 420 nm existed on the GO–DEX of GO-DEX-Apt absorption spectrum (Fig. 3D). The loading of CUR onto the surface of either GO-DEX or GO-DEX-Apt can be attributed to π-π stacking interactions as reported previously for loading of hydrophobic drugs onto single walled carbon nanotubes (SWCNT) (H. Li et al., 2014). The encapsulation efficiency of CUR in GO-DEX and GO-DEX-Apt were 69.5±11.42 and 72.08±13.74, respectively and the drug loading of CUR in GO-DEX and GO-DEX-Apt were also calculated to be 27.8% ±6.25 and 29.12±3.49, respectively. In our study, AS1411 aptamer-conjugated GO–DEX was used to target specific cancer cells. In comparison with single-walled carbon nanotubes for drug loading via π-stacking interaction (Naderi, Madani, Mosahebi, & Seifalian, 2015), GO is superior in terms of its low cost (X. Zhang, Yang, Zhou, & Huo, 2016). The release profiles of GO-DEX-CUR and GO-DEX-Apt-CUR were found to be virtually similar, demonstrating that the aptamer functionalization on the GO-DEX sheets surface does not affect the CUR release rate while increase cellular uptake, leading to better therapeutic efficiency. Drug release from either GO–DEX or GO-DEX-Apt sheets was examined in PBS pH 7.4 and citrate buffer pH 5.5. It was observed that ∼70% of CUR loaded on either GO–DEX or GODEX-Apt was released over 2 days in an acidic solution of pH 5.5 (Fig. 4A, B), which was attributed to the decreased interactions between the drug and the GO sheets at an acidic pH which could be due to enhancement of solubility and hydrophilicity of CUR (Dinarvand,\n17 | P a g e\nSepehri, Manoochehri, Rouhani, & Atyabi, 2011). In contrast, the release rate in pH 7.4 was only 20-30% over 2 days. This pH-dependent drug release profile from both GO–DEX and GO-DEX-Apt could be implemented for anticancer drug delivery applications due to the acidic pH environment of tumor tissues, lysosomes and endosomes, which will enhance active drug release from aforementioned delivery vehicles and consequently increase the therapeutic potency of the system.\n3.3. Cellular uptake using flowcytometry\nThe pivotal characteristic of a targeted drug-delivery system is its specificity toward specific cancer cells. To investigate the in vitro cancer targeting of GO-DEX-Apt against nucleolinoverexpressing cells, this study explore the cellular uptake of 4T1 and MCF-7 cell lines using a flow-cytometry analysis (Fig. 5A, B). GO-DEX-CUR, GO-DEX-Apt-CUR, and free CUR were co-cultured with 4T1 and MCF-7 cell lines. As a negative control, excess amounts (2 μg/well) of free AS1411 aptamer were added to the wells 30 min before the addition of GO-DEX-Apt-CUR. The fluorescent intensity of 4T1 and MCF-7 cells incubated with GO-DEX-CUR was similar to that of cells treated with free aptamer prior to the addition of GO-DEX-Apt-CUR. The addition of excess aptamer as a free, competing ligand for targeted nanostructure prior to the cellular-uptake experiment decreased the aptamer-targeted efficiency. However, for GO-DEX-Apt-CUR -treated 4T1 and MCF-7 cells, the fluorescent intensity increased by 65% and 83% respectively, while that of GO-DEX-CUR -treated 4T1 and MCF-7 cells increased by 41% and 56%. This difference in fluorescence intensity was caused by the conjugated aptamer (in GO-DEX-Apt-CUR) attachment to nucleolin proteins on the 4T1 and MCF-7 cell surfaces, resulting in enhanced nanostructures cell internalization. Then AS1411 aptamer modification of GO-DEX enhanced the uptake of nanosystem by nucleolin -over-expressing 4T1 and MCF-7 cell lines.\n18 | P a g e\nOn the other hand, cellular uptake of GO-DEX-CUR was comparable with that of curcumin. Why GO-DEX-CUR did not show significantly higher efficacy than curcumin is not clear. In this regard Zhao and co-workers also reported the same cellular uptake for free CUR and CUR-loaded lipid-polymer hybrid nanoparticles(Zhao et al., 2014).\n3.4. Cellular uptake using fluorescent microscopy\nThe flowcytometry results indicate that the GO-DEX-Apt-CUR enhanced fluorescence intensity in nucleolin-positive 4T1 and MCF-7 cells compared with GO-DEX-CUR. However, it was not definitely clear whether the GO-DEX-Apt-CUR was internalized into the cytoplasm of the cells. Then in order to examine the interaction between GO-DEX-AptCUR and the target cells, then, fluorescent microscopy was used to illustrate the GO-DEXApt-CUR locations. As indicated in Fig. 6, the GO-DEX-Apt-CUR was mainly accumulated within the cells. It was clear that GO-DEX-Apt-CUR was internalized into the 4T1 and MCF7 cells and could deliver CUR into the cytoplasm of the cells. Compared to GO-DEX-AptCUR, far fewer GO-DEX-CUR, free aptamer treated cells and CUR entered the 4T1 and MCF-7 cells, confirming that conjugation of AS1411 aptamer to GO-DEX-CUR increased the cell uptake of the composite.\n3.5. In vitro cellular cytotoxicity (MTT) assays\nThe cytotoxicity of GO-DEX versus GO was performed by incubating 4T1 and MCF-7 cells with various concentrations of GO-DEX and GO for 24 or 48 h. We observed slight reductions of cell viability only at extremely high GO–DEX concentrations (~300 µg/mL). In contrast to GO-DEX, GO showed high cytotoxicity at lower concentrations (Figure 7A, B). In all of our cellular experiments for the prepared formulations, we implemented a carrier concentration below the level having any pronounced toxic effect on the cells. Obtained results proved that DEX conjugation to GO made it extremely biocompatible.\n19 | P a g e\nIn order to examine the cellular toxicity of GO-DEX-CUR, GO-DEX-Apt-CUR, and free CUR, we incubated the composites and free CUR with 4T1 and MCF7 cells as nucleolin positive cells and CHO cell line as nucleolin negative cell. Enhanced CUR delivery and cytotoxicity was verified by comparison with 4T1 (Fig. 7B, C) and MCF-7 (Fig. 7E, F) cells treated with free CUR, GO-DEX-CUR and GO-DEX-Apt-CUR. It should be noted that the in vitro selectivity is limited by the passive uptake of GO-DEXCUR. At high CUR concentrations, the passive uptake is high so that cells are killed by either GO-DEX-CUR or GO-DEX-Apt-CUR. Therefore, there is a maximum dosage window in which the selective cell killing can be observed. This phenomenon is familiar for many other targeted drug delivery systems. The present data suggests that GO-DEX-Apt-CUR are significantly more cytotoxic compared with free CUR or GO-DEX-CUR in MCF-7 or 4T1 cells while the toxicities of CUR or GODEX-CUR and GO-DEX-Apt-CUR were similar in CHO cell line (Fig. 7G) as a negative control (p > 0.05). This is consistent with the results shown in Fig. 6A, B, which demonstrates the AS1411 aptamer increasing GO-DEX-Apt-CUR uptake for 4T1 and MCF-7 cells. These results suggest that the GO-DEX-Apt-CUR enhanced toxicity was due to the high affinity and selectivity of aptamer-conjugated GO-DEX-CUR for 4T1 and MCF-7 cells during incubation. The result indicated that GO-DEX-Apt could be loaded with CUR to attain a more efficient treatment compared to that of GO-DEX-CUR and free CUR. Although the nucleolin protein as a crucial biomarker is overexpressed on the surface of various types of cancer cells, the developed targeted GO-based drug delivery system may seriously improve the delivery of hydrophobic therapeutic molecules into nucleolin-\n20 | P a g e\noverexpressing cancer cells. Our results suggest that AS1411-targeted GO-DEX is capable candidates for chemotherapy administration. Previous studies on GO-conjugated PEG for drug delivery have improved efficacy of paclitaxel against breast adenocarcinoma (MCF-7), non-small cell lung cancer (A549) and prostate cancer (Thapa et al., 2016; Z. Xu et al., 2014). Another studies proved the efficacy of DOX-loaded GO-hematin terminated DEX nanohybrid against drug resistance MCF-7 (MCF-7/ADR). The obtained results demonstrated the enhanced cytotoxicity and uptake of GO-DEX/DOX systems (Jin, Ji, Yang, Wang, & Cao, 2013). In this regard, Hu and co-workers prepared the DEX-decorated reduced GO for targeted delivery of DOX via conjugation of RGD oligopeptide which could improve the intracellular uptake by αvß3 recognition (Y. Hu et al., 2016). Targeted drug delivery systems have been designed to overcome the bottleneck in anticancer therapy that most anticancer agents are incapable to act specifically on cancer cells and cause toxicity to normal cells (Iversen, Skotland, & Sandvig, 2011). In this study, we designed a biocompatible DEX-conjugated graphene oxide targeted with AS1411 aptamer to enhance the delivery of CUR to nucleolin-overexpressing 4T1 and MCF7 tumor cells. However, it would be perfect to prepare an aptamer targeted drug delivery system for a wide range of cancers. Nucleolin protein is overexpressed on the surface of broad spectrum of adenocarcinoma cells (J. Liu et al., 2016), making it an ideal target for cancer therapy. AS1411 is the first single strand DNA aptamer to reach phases I and II clinical trials (Mongelard & Bouvet, 2010). AS1411 can attach to nucleolin with high affinity and is then penetrated into the tumor cells, comprising in colorectal, breast, prostate, and NSCLC (Liao et al., 2015; Tang et al., 2015; Zhong, Meng, Deng, & Zhong, 2014). Furthermore, AS1411 Apt is resistant to DNase/RNase degradation and remains intact in plasma (Đapic et al.,\n21 | P a g e\n2002). It has been effectively used as a targeting ligand in numerous drug delivery systems (Alibolandi, Abnous, Ramezani, Hosseinkhani, & Hadizadeh, 2014; Alibolandi, Ramezani, et al., 2016; Taghdisi et al., 2016; Zhuang et al., 2016). In this regard, AS1411 is a unique ligand for aptamer-based guided drug delivery to treat various adenocarcinomas. In this study, for the first time, AS1411 aptamer is exploited as a targeting agent in a GODEX-based curcumin delivery system. The GO-DEX-Apt was evaluated for its targeting capability against the 4T1 and MCF-7 cells in vitro. We observed enhanced uptake and cytotoxicity of GO-DEX-Apt-CUR by 4T1 and MCF-7 cells in comparison with GO-DEXCUR and free CUR. Our results suggest that nanoscale AS1411 aptamer-conjugated GO-DEX vehicle offers an effective strategy to deliver therapeutically effective CUR (highly hydrophobic antineoplastic natural product) concentrations into the mice metastatic breast cancer 4T1 cell line.\n4. Conclusion\nThe AS1411 functional GO-DEX-Apt-CUR, with nanoscale dimension and high loading capacity, were prepared. The AS1411 aptamer functional GO-DEX have been successfully developed as a potential drug delivery system, and the poorly soluble anti-cancer agent CUR as model was loaded on the surface of GO-DEX sheets via π-π stacking interactions. The GO-DEX-Apt-CUR composites are nanoscale with a size less than 200 nm, and demonstrated enhanced nucleolin positive cellular uptake and in vitro pH responsive drug release behaviour. The in vitro cytotoxicity was evaluated on the 4T1 and MCF-7 cell lines using MTT assay and demonstrated that GO-DEX-Apt-CUR significantly enhanced the cytotoxicity of CUR for 4T1 and MCF-7 cells and increased cellular uptake in comparison with not-targeted and also free CUR treated cells.\n22 | P a g e\nAlthough further investigations on this extremely biocompatible GO-DEX-based drug delivery system are required, the findings of our study represent an extension for the use of GO-DEX-Apt as a potential strategy for novel drug delivery systems."
    }, {
      "heading" : "Acknowledgement",
      "text" : "The authors are grateful for the financial support provided by the Mashhad University of Medical Sciences (No. 930872). The authors would also like to thank Dr. Majid Darroudi from the School of Medicine, Mashhad University of Medical Sciences for the valuable assistance provided for SEM images preparation."
    }, {
      "heading" : "Declaration of Interest",
      "text" : "The authors declare that they have no conflicts of interests.\n23 | P a g e"
    } ],
    "references" : [ {
      "title" : "Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets",
      "author" : [ "B.B. Aggarwal", "B. Sung" ],
      "venue" : "Trends in pharmacological sciences,",
      "citeRegEx" : "Aggarwal and Sung,? \\Q2009\\E",
      "shortCiteRegEx" : "Aggarwal and Sung",
      "year" : 2009
    }, {
      "title" : "Synthesis of AS1411-Aptamer-Conjugated CdTe quantum dots with high fluorescence strength for probe labeling tumor cells",
      "author" : [ "M. Alibolandi", "K. Abnous", "M. Ramezani", "H. Hosseinkhani", "F. Hadizadeh" ],
      "venue" : "Journal of fluorescence,",
      "citeRegEx" : "Alibolandi et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Alibolandi et al\\.",
      "year" : 2014
    }, {
      "title" : "Dextran-b-poly (lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation",
      "author" : [ "M. Alibolandi", "F. Alabdollah", "F. Sadeghi", "M. Mohammadi", "K. Abnous", "M. Ramezani", "F. Hadizadeh" ],
      "venue" : "Journal of Controlled Release,",
      "citeRegEx" : "Alibolandi et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Alibolandi et al\\.",
      "year" : 2016
    }, {
      "title" : "Design and fabrication of an aptasensor for chloramphenicol based on energy transfer of CdTe quantum dots to graphene oxide sheet",
      "author" : [ "M. Alibolandi", "F. Hadizadeh", "F. Vajhedin", "K. Abnous", "M. Ramezani" ],
      "venue" : "Materials Science and Engineering: C,",
      "citeRegEx" : "Alibolandi et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Alibolandi et al\\.",
      "year" : 2015
    }, {
      "title" : "AS1411 AptamerDecorated Biodegradable Polyethylene Glycol–Poly (lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non–Small Cell Lung Cancer In Vitro",
      "author" : [ "M. Alibolandi", "M. Ramezani", "K. Abnous", "F. Hadizadeh" ],
      "venue" : "Journal of pharmaceutical sciences,",
      "citeRegEx" : "Alibolandi et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Alibolandi et al\\.",
      "year" : 2016
    }, {
      "title" : "In vitro and in vivo evaluation of therapy targeting epithelial",
      "author" : [ "M. Alibolandi", "M. Ramezani", "K. Abnous", "F. Sadeghi", "F. Atyabi", "M. Asouri", "F. . . Hadizadeh" ],
      "venue" : null,
      "citeRegEx" : "Alibolandi et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Alibolandi et al\\.",
      "year" : 2015
    }, {
      "title" : "The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model",
      "author" : [ "M. Alibolandi", "F. Sadeghi", "K. Abnous", "F. Atyabi", "M. Ramezani", "F. Hadizadeh" ],
      "venue" : "European Journal of Pharmaceutics and Biopharmaceutics,",
      "citeRegEx" : "Alibolandi et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Alibolandi et al\\.",
      "year" : 2015
    }, {
      "title" : "Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles",
      "author" : [ "A. Anitha", "V. Deepagan", "V.D. Rani", "D. Menon", "S. Nair", "R. Jayakumar" ],
      "venue" : "Carbohydrate polymers,",
      "citeRegEx" : "Anitha et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Anitha et al\\.",
      "year" : 2011
    }, {
      "title" : "Biocompatible hyperbranched epoxy/silver–reduced graphene oxide–curcumin nanocomposite as an advanced antimicrobial material",
      "author" : [ "S. Barua", "P. Chattopadhyay", "M.M. Phukan", "B.K. Konwar", "J. Islam", "N. Karak" ],
      "venue" : "RSC Advances,",
      "citeRegEx" : "Barua et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Barua et al\\.",
      "year" : 2014
    }, {
      "title" : "Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar",
      "author" : [ "V. Đapic", "P.J. Bates", "J.O. Trent", "A. Rodger", "S.D. Thomas", "D.M. Miller" ],
      "venue" : "modifications. Biochemistry,",
      "citeRegEx" : "Đapic et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Đapic et al\\.",
      "year" : 2002
    }, {
      "title" : "Polylactideco-glycolide nanoparticles for controlled delivery of anticancer agents",
      "author" : [ "R. Dinarvand", "N. Sepehri", "S. Manoochehri", "H. Rouhani", "F. Atyabi" ],
      "venue" : "Int J Nanomedicine,",
      "citeRegEx" : "Dinarvand et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Dinarvand et al\\.",
      "year" : 2011
    }, {
      "title" : "Dual HER2 targeting with trastuzumab and liposome-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer",
      "author" : [ "C.W. Espelin", "S.C. Leonard", "E. Geretti", "T.J. Wickham", "B.S. Hendriks" ],
      "venue" : "Cancer research,",
      "citeRegEx" : "Espelin et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Espelin et al\\.",
      "year" : 2016
    }, {
      "title" : "Precise glioma targeting of and penetration by aptamer and peptide",
      "author" : [ "H. Gao", "J. Qian", "S. Cao", "Z. Yang", "Z. Pang", "S. Pan", "Q. . . Zhang" ],
      "venue" : "dual-functioned nanoparticles. Biomaterials,",
      "citeRegEx" : "Gao et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Gao et al\\.",
      "year" : 2012
    }, {
      "title" : "Phospholipid− dextran with a single coupling point: A useful amphiphile for functionalization of nanomaterials",
      "author" : [ "A.P. Goodwin", "S.M. Tabakman", "K. Welsher", "S.P. Sherlock", "G. Prencipe", "H. Dai" ],
      "venue" : "Journal of the American Chemical Society,",
      "citeRegEx" : "Goodwin et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Goodwin et al\\.",
      "year" : 2008
    }, {
      "title" : "Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin",
      "author" : [ "A. Hakeem", "F. Zahid", "R. Duan", "M. Asif", "T. Zhang", "Z. Zhang", "F. . . Xia" ],
      "venue" : "release. Nanoscale,",
      "citeRegEx" : "Hakeem et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Hakeem et al\\.",
      "year" : 2016
    }, {
      "title" : "Curcumin-reduced graphene oxide sheets and their effects on human breast cancer cells",
      "author" : [ "S. Hatamie", "O. Akhavan", "S.K. Sadrnezhaad", "M.M. Ahadian", "M.M. Shirolkar", "H.Q. Wang" ],
      "venue" : "Materials Science and Engineering: C,",
      "citeRegEx" : "Hatamie et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Hatamie et al\\.",
      "year" : 2015
    }, {
      "title" : "Therapeutic nanoparticles to combat cancer drug resistance",
      "author" : [ "Hu", "C.-M. J", "L. Zhang" ],
      "venue" : "Current drug metabolism,",
      "citeRegEx" : "Hu et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Hu et al\\.",
      "year" : 2009
    }, {
      "title" : "Redox and pH dual responsive poly (amidoamine) dendrimer-poly (ethylene glycol) conjugates for intracellular delivery of doxorubicin",
      "author" : [ "W. Hu", "L. Qiu", "L. Cheng", "Q. Hu", "Y. Liu", "Z. Hu", "L. . . Cheng" ],
      "venue" : "Acta biomaterialia,",
      "citeRegEx" : "Hu et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Hu et al\\.",
      "year" : 2016
    }, {
      "title" : "One-pot synthesis of dextran decorated reduced graphene oxide nanoparticles for targeted photo-chemotherapy",
      "author" : [ "Y. Hu", "L. He", "J. Ding", "D. Sun", "L. Chen", "X. Chen" ],
      "venue" : "Carbohydrate polymers,",
      "citeRegEx" : "Hu et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Hu et al\\.",
      "year" : 2016
    }, {
      "title" : "Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies",
      "author" : [ "Iversen", "T.-G", "T. Skotland", "K. Sandvig" ],
      "venue" : "Nano Today,",
      "citeRegEx" : "Iversen et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Iversen et al\\.",
      "year" : 2011
    }, {
      "title" : "Self-assembled graphene–dextran nanohybrid for killing drug-resistant cancer cells",
      "author" : [ "R. Jin", "X. Ji", "Y. Yang", "H. Wang", "A. Cao" ],
      "venue" : "ACS applied materials & interfaces,",
      "citeRegEx" : "Jin et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Jin et al\\.",
      "year" : 2013
    }, {
      "title" : "Cell surface nucleolin as a target for anticancer therapies",
      "author" : [ "M. Koutsioumpa", "E. Papadimitriou" ],
      "venue" : "Recent patents on anti-cancer drug discovery,",
      "citeRegEx" : "Koutsioumpa and Papadimitriou,? \\Q2014\\E",
      "shortCiteRegEx" : "Koutsioumpa and Papadimitriou",
      "year" : 2014
    }, {
      "title" : "Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity",
      "author" : [ "I. Levacheva", "O. Samsonova", "E. Tazina", "M. Beck-Broichsitter", "S. Levachev", "B. Strehlow", "U. . . Bakowsky" ],
      "venue" : "proof. Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "Levacheva et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Levacheva et al\\.",
      "year" : 2014
    }, {
      "title" : "Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro",
      "author" : [ "H. Li", "N. Zhang", "Y. Hao", "Y. Wang", "S. Jia", "H. Zhang", "Z. . . Zhang" ],
      "venue" : "Drug delivery,",
      "citeRegEx" : "Li et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2014
    }, {
      "title" : "A theranostic prodrug delivery system based on Pt(IV) conjugated nano-graphene oxide with synergistic effect to enhance the therapeutic efficacy",
      "author" : [ "J. Li", "Z. Lyv", "Y. Li", "H. Liu", "J. Wang", "W. Zhan", "X. . . Li" ],
      "venue" : "Pt drug. Biomaterials,",
      "citeRegEx" : "Li et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2015
    }, {
      "title" : "Aptamer photoregulation in vivo",
      "author" : [ "L. Li", "R. Tong", "H. Chu", "W. Wang", "R. Langer", "D.S. Kohane" ],
      "venue" : "Proceedings of the National Academy of Sciences,",
      "citeRegEx" : "Li et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2014
    }, {
      "title" : "An AS1411 aptamer-conjugated liposomal system containing a bubblegenerating agent for tumor-specific chemotherapy that overcomes multidrug resistance",
      "author" : [ "Liao", "Z.-X", "Chuang", "E.-Y", "Lin", "C.-C", "Ho", "Y.-C", "K.-J", "Cheng", "P.-Y", ". . Sung", "H.-W" ],
      "venue" : "Journal of Controlled Release,",
      "citeRegEx" : "Liao et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Liao et al\\.",
      "year" : 2015
    }, {
      "title" : "Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer",
      "author" : [ "J. Liu", "T. Wei", "J. Zhao", "Y. Huang", "H. Deng", "A. Kumar", ". . Liang", "X.-J" ],
      "venue" : "resistance. Biomaterials,",
      "citeRegEx" : "Liu et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Liu et al\\.",
      "year" : 2016
    }, {
      "title" : "Expansile crosslinked polymersomes for pH sensitive delivery of doxorubicin",
      "author" : [ "X. Liu", "M.J. Yaszemski", "L. Lu" ],
      "venue" : "Biomaterials science",
      "citeRegEx" : "Liu et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Liu et al\\.",
      "year" : 2016
    }, {
      "title" : "PEGylated nanographene oxide for delivery of water-insoluble cancer drugs",
      "author" : [ "Z. Liu", "J.T. Robinson", "X. Sun", "H. Dai" ],
      "venue" : "Journal of the American Chemical Society,",
      "citeRegEx" : "Liu et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Liu et al\\.",
      "year" : 2008
    }, {
      "title" : "Graphene oxide as a chemically tunable platform for optical applications",
      "author" : [ "K.P. Loh", "Q. Bao", "G. Eda", "M. Chhowalla" ],
      "venue" : "Nature chemistry,",
      "citeRegEx" : "Loh et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Loh et al\\.",
      "year" : 2010
    }, {
      "title" : "Aptamer-functionalized graphene oxide for highly efficient loading and cancer cell-specific delivery of antitumor drug",
      "author" : [ "Y. Lu", "P. Wu", "Y. Yin", "H. Zhang", "C. Cai" ],
      "venue" : "Journal of Materials Chemistry B,",
      "citeRegEx" : "Lu et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Lu et al\\.",
      "year" : 2014
    }, {
      "title" : "Carbohydrate coated, folate functionalized colloidal graphene as a nanocarrier for both hydrophobic and hydrophilic drugs",
      "author" : [ "A.R. Maity", "A. Chakraborty", "A. Mondal", "N.R. Jana" ],
      "venue" : null,
      "citeRegEx" : "Maity et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Maity et al\\.",
      "year" : 2014
    }, {
      "title" : "AS1411-conjugated gold nanospheres and their potential for breast cancer",
      "author" : [ "M.T. Malik", "M.G. O'Toole", "L.K. Casson", "S.D. Thomas", "G.T. Bardi", "E.M. Reyes-Reyes", "P.J. . . Bates" ],
      "venue" : "therapy. Oncotarget,",
      "citeRegEx" : "Malik et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Malik et al\\.",
      "year" : 2015
    }, {
      "title" : "Improved synthesis of graphene oxide",
      "author" : [ "D.C. Marcano", "D.V. Kosynkin", "J.M. Berlin", "A. Sinitskii", "Z. Sun", "A. Slesarev", "J.M. . . Tour" ],
      "venue" : "ACS nano,",
      "citeRegEx" : "Marcano et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Marcano et al\\.",
      "year" : 2010
    }, {
      "title" : "BiotinContaining Reduced Graphene Oxide-Based Nanosystem as a Multieffect Anticancer Agent: Combining Hyperthermia with Targeted Chemotherapy",
      "author" : [ "N. Mauro", "C. Scialabba", "G. Cavallaro", "M. Licciardi", "G. Giammona" ],
      "venue" : "Biomacromolecules,",
      "citeRegEx" : "Mauro et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Mauro et al\\.",
      "year" : 2015
    }, {
      "title" : "AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia",
      "author" : [ "F. Mongelard", "P. Bouvet" ],
      "venue" : "Current opinion in molecular therapeutics,",
      "citeRegEx" : "Mongelard and Bouvet,? \\Q2010\\E",
      "shortCiteRegEx" : "Mongelard and Bouvet",
      "year" : 2010
    }, {
      "title" : "Octa-ammonium POSSconjugated single-walled carbon nanotubes as vehicles for targeted delivery of paclitaxel",
      "author" : [ "N. Naderi", "S.Y. Madani", "A. Mosahebi", "A.M. Seifalian" ],
      "venue" : "Nano reviews,",
      "citeRegEx" : "Naderi et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Naderi et al\\.",
      "year" : 2015
    }, {
      "title" : "Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer",
      "author" : [ "O. Naksuriya", "S. Okonogi", "R.M. Schiffelers", "W.E. Hennink" ],
      "venue" : "treatment. Biomaterials,",
      "citeRegEx" : "Naksuriya et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Naksuriya et al\\.",
      "year" : 2014
    }, {
      "title" : "Co-Adsorption of Doxorubicin and Selected Dyes on Carbon Nanotubes. Theoretical Investigation of Potential Application as pH Controlled Drug Delivery System. Langmuir",
      "author" : [ "T. Panczyk", "P. Wolski", "L. Lajtar" ],
      "venue" : null,
      "citeRegEx" : "Panczyk et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Panczyk et al\\.",
      "year" : 2016
    }, {
      "title" : "Curcumin entrapped folic acid conjugated PLGA–PEG nanoparticles exhibit enhanced anticancer activity by site specific delivery",
      "author" : [ "J.J. Pillai", "A.K.T. Thulasidasan", "R.J. Anto", "N.C. Devika", "N. Ashwanikumar", "G.V. Kumar" ],
      "venue" : "RSC Adv.,",
      "citeRegEx" : "Pillai et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Pillai et al\\.",
      "year" : 2015
    }, {
      "title" : "Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives",
      "author" : [ "S. Some", "Gwon", "A.-R", "E. Hwang", "Bahn", "G.-h", "Y. Yoon", "Y. Kim", ". . Jo", "D.-G" ],
      "venue" : "Scientific reports,",
      "citeRegEx" : "Some et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Some et al\\.",
      "year" : 2014
    }, {
      "title" : "The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient",
      "author" : [ "Y. Song", "Z. Huang", "Q. Tian", "X. Liu", "Z. She", "Y. . . Deng" ],
      "venue" : "International journal of nanomedicine,",
      "citeRegEx" : "Song et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Song et al\\.",
      "year" : 2014
    }, {
      "title" : "Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo",
      "author" : [ "S.M. Taghdisi", "N.M. Danesh", "M. Ramezani", "P. Lavaee", "S.H. Jalalian", "R.Y. Robati", "K. Abnous" ],
      "venue" : "European Journal of Pharmaceutics and Biopharmaceutics,",
      "citeRegEx" : "Taghdisi et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Taghdisi et al\\.",
      "year" : 2016
    }, {
      "title" : "An aptamer-targeting photoresponsive drug delivery system using “off–on” graphene oxide wrapped mesoporous silica",
      "author" : [ "Y. Tang", "H. Hu", "M.G. Zhang", "J. Song", "L. Nie", "S. Wang", "X. . . Chen" ],
      "venue" : "nanoparticles. Nanoscale,",
      "citeRegEx" : "Tang et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Tang et al\\.",
      "year" : 2015
    }, {
      "title" : "Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells",
      "author" : [ "R.K. Thapa", "Y.S. Youn", "Jeong", "J.-H", "Choi", "H.-G", "C.S. Yong", "J.O. Kim" ],
      "venue" : "Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "Thapa et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Thapa et al\\.",
      "year" : 2016
    }, {
      "title" : "EGCG/gelatindoxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer",
      "author" : [ "Tsai", "L.-C", "Hsieh", "H.-Y", "Lu", "K.-Y", "Wang", "S.-Y", "Mi", "F.-L" ],
      "venue" : "treatment. Nanomedicine,",
      "citeRegEx" : "Tsai et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Tsai et al\\.",
      "year" : 2016
    }, {
      "title" : "Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death",
      "author" : [ "K. Wang", "C. Zhang", "J. Bao", "X. Jia", "Y. Liang", "X. Wang", ". . Wan", "J.-B" ],
      "venue" : "Scientific reports,",
      "citeRegEx" : "Wang et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2016
    }, {
      "title" : "Aqueous synthesis of peptide thioesters from amino acids and a thiol using 1, 1′-carbonyldiimidazole",
      "author" : [ "A.L. Weber" ],
      "venue" : "Origins of Life and Evolution of Biospheres,",
      "citeRegEx" : "Weber,? \\Q2005\\E",
      "shortCiteRegEx" : "Weber",
      "year" : 2005
    }, {
      "title" : "Non-covalent modification of graphene oxide nanocomposites with chitosan/dextran and its application in drug delivery",
      "author" : [ "M. Xie", "H. Lei", "Y. Zhang", "Y. Xu", "S. Shen", "Y. Ge", "J. . . Xie" ],
      "venue" : "RSC Advances,",
      "citeRegEx" : "Xie et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Xie et al\\.",
      "year" : 2016
    }, {
      "title" : "Flexible graphene films via the filtration of water-soluble noncovalent functionalized graphene sheets",
      "author" : [ "Y. Xu", "H. Bai", "G. Lu", "C. Li", "G. Shi" ],
      "venue" : "Journal of the American Chemical Society,",
      "citeRegEx" : "Xu et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Xu et al\\.",
      "year" : 2008
    }, {
      "title" : "Covalent functionalization of graphene oxide with biocompatible poly (ethylene glycol) for delivery of paclitaxel",
      "author" : [ "Z. Xu", "S. Wang", "Y. Li", "M. Wang", "P. Shi", "X. Huang" ],
      "venue" : "ACS applied materials & interfaces,",
      "citeRegEx" : "Xu et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Xu et al\\.",
      "year" : 2014
    }, {
      "title" : "Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin",
      "author" : [ "Yan", "J.-K", "Ma", "H.-L", "X. Chen", "Pei", "J.-J", "Wang", "Z.-B", "Wu", "J.-Y" ],
      "venue" : "International journal of biological macromolecules,",
      "citeRegEx" : "Yan et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Yan et al\\.",
      "year" : 2015
    }, {
      "title" : "In Vivo Targeting of Metastatic Breast Cancer via Tumor VasculatureSpecific Nano-Graphene Oxide. Biomaterials",
      "author" : [ "D. Yang", "L. Feng", "C.A. Dougherty", "K.E. Luker", "D. Chen", "M.A. Cauble", "Z. . . Liu" ],
      "venue" : null,
      "citeRegEx" : "Yang et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Yang et al\\.",
      "year" : 2016
    }, {
      "title" : "Biosensing platform based on fluorescence resonance energy transfer from upconverting nanocrystals to graphene oxide",
      "author" : [ "C. Zhang", "Y. Yuan", "S. Zhang", "Y. Wang", "Z. Liu" ],
      "venue" : "Angewandte Chemie International Edition,",
      "citeRegEx" : "Zhang et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2011
    }, {
      "title" : "Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs",
      "author" : [ "L. Zhang", "J. Xia", "Q. Zhao", "L. Liu", "Z. Zhang" ],
      "venue" : null,
      "citeRegEx" : "Zhang et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2010
    }, {
      "title" : "In vitro and in vivo behaviors of dextran functionalized graphene",
      "author" : [ "S. Zhang", "K. Yang", "L. Feng", "Z. Liu" ],
      "venue" : null,
      "citeRegEx" : "Zhang et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2011
    }, {
      "title" : "Somatostatin Receptor‐Mediated Tumor‐Targeting Nanocarriers Based on Octreotide‐PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy",
      "author" : [ "X. Zhang", "C. Yang", "J. Zhou", "M. Huo" ],
      "venue" : null,
      "citeRegEx" : "Zhang et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2016
    }, {
      "title" : "Intracellular pHSensitive PEG-block-Acetalated-Dextrans as Efficient Drug Delivery Platforms",
      "author" : [ "Z. Zhang", "X. Chen", "L. Chen", "S. Yu", "Y. Cao", "C. He" ],
      "venue" : "ACS applied materials & interfaces,",
      "citeRegEx" : "Zhang et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2013
    }, {
      "title" : "Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery",
      "author" : [ "Y. Zhao", "D. Lin", "F. Wu", "L. Guo", "G. He", "L. Ouyang", "X. . . Li" ],
      "venue" : "International Journal of Molecular Sciences,",
      "citeRegEx" : "Zhao et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Zhao et al\\.",
      "year" : 2014
    }, {
      "title" : "Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy",
      "author" : [ "Y. Zhong", "F. Meng", "C. Deng", "Z. Zhong" ],
      "venue" : "Biomacromolecules,",
      "citeRegEx" : "Zhong et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Zhong et al\\.",
      "year" : 2014
    }, {
      "title" : "AptamerFunctionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy. Biomacromolecules",
      "author" : [ "Y. Zhuang", "H. Deng", "Y. Su", "L. He", "R. Wang", "G. Tong", "X. . . Zhu" ],
      "venue" : null,
      "citeRegEx" : "Zhuang et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Zhuang et al\\.",
      "year" : 2016
    } ],
    "referenceMentions" : [ {
      "referenceID" : 14,
      "context" : "mesoporous silica (Hakeem et al., 2016) or carbonaceous materials (Panczyk, Wolski, & Lajtar, 2016).",
      "startOffset" : 18,
      "endOffset" : 39
    }, {
      "referenceID" : 24,
      "context" : "are not only used as drug delivery platforms but also act as hyperthermia agent in photothermal therapy to elevate the cytotoxicity of antineoplastic agents in lower doses or to regulate the drug release profile (Li et al., 2015; Mauro, Scialabba, Cavallaro, Licciardi, & Giammona, 2015).",
      "startOffset" : 212,
      "endOffset" : 287
    }, {
      "referenceID" : 53,
      "context" : "developing biosensors and imaging contrast agents (Yang et al., 2016; C. Zhang, Yuan, Zhang, Wang, & Liu, 2011).",
      "startOffset" : 50,
      "endOffset" : 111
    }, {
      "referenceID" : 13,
      "context" : "Studies demonstrated that DEX coated nanoparticles are more colloidal stable than those coated with PEG chains (Goodwin et al., 2008).",
      "startOffset" : 111,
      "endOffset" : 133
    }, {
      "referenceID" : 49,
      "context" : "Also, DEX-coated nanoparticles are less prone to non-specific protein adsorption(Xie et al., 2016; S. Zhang et al., 2011).",
      "startOffset" : 80,
      "endOffset" : 121
    }, {
      "referenceID" : 8,
      "context" : "Many studies proved its antimicrobial(Barua et al., 2014), anti-inflammatory (Hatamie",
      "startOffset" : 37,
      "endOffset" : 57
    }, {
      "referenceID" : 40,
      "context" : "The anticancer properties of CUR are due to the down-regulation of different transcription factors such as NF-kB, AP-1 and betacatenin (Pillai et al., 2015).",
      "startOffset" : 135,
      "endOffset" : 156
    }, {
      "referenceID" : 12,
      "context" : "Recently, it was demonstrated that targeted delivery of nanomedicine could be a promising approach to specifically deliver the drug to the target cell population and reduce the undesired effects associated with anticancer agents (Gao et al., 2012).",
      "startOffset" : 229,
      "endOffset" : 247
    }, {
      "referenceID" : 33,
      "context" : "Accumulating evidences validated that cell surface nucleolin acted together with protein complexes associated with tumorgenesis and angiogenesis suggesting that nanoparticle-conjugated aptamer could enhance the cellular uptake and the efficiency of the drug delivery while reducing the side effects associated with the cytotoxic drugs (Koutsioumpa & Papadimitriou, 2014; Malik et al., 2015).",
      "startOffset" : 335,
      "endOffset" : 390
    }, {
      "referenceID" : 7,
      "context" : "In vitro drug release profile of curcumin from drug GO-DEX-CUR (10 mg) or GO-DEXApt-CUR were done by direct dispersion method as reported previously(Anitha et al., 2011).",
      "startOffset" : 148,
      "endOffset" : 169
    }, {
      "referenceID" : 33,
      "context" : "In this study the nanoscale good quality graphene oxide sheets were prepared from graphite flakes using a modified Hummers’ method (Malik et al., 2015).",
      "startOffset" : 131,
      "endOffset" : 151
    }, {
      "referenceID" : 22,
      "context" : "targeting through enhanced permeation and retention (EPR) effects, which enhance the therapeutic index of carried drug (Levacheva et al., 2014; Song et al., 2014; Yan et al., 2015).",
      "startOffset" : 119,
      "endOffset" : 180
    }, {
      "referenceID" : 42,
      "context" : "targeting through enhanced permeation and retention (EPR) effects, which enhance the therapeutic index of carried drug (Levacheva et al., 2014; Song et al., 2014; Yan et al., 2015).",
      "startOffset" : 119,
      "endOffset" : 180
    }, {
      "referenceID" : 52,
      "context" : "targeting through enhanced permeation and retention (EPR) effects, which enhance the therapeutic index of carried drug (Levacheva et al., 2014; Song et al., 2014; Yan et al., 2015).",
      "startOffset" : 119,
      "endOffset" : 180
    }, {
      "referenceID" : 48,
      "context" : "When the CDI concentration was 60 mg in the reaction mixture, ~90% of aptamer was conjugated to DEX molecules (Weber, 2005).",
      "startOffset" : 110,
      "endOffset" : 123
    }, {
      "referenceID" : 47,
      "context" : "Next, we evaluated the potency of GO-DEX as nanoscale sheet-like vehicles to carry an hydrophobic drug curcumin (CUR), a natural polyphenol, found in the rhizomes of Curcuma longa (turmeric) which showed anticancer effect (Wang et al., 2016).",
      "startOffset" : 222,
      "endOffset" : 241
    }, {
      "referenceID" : 59,
      "context" : "In this regard Zhao and co-workers also reported the same cellular uptake for free CUR and CUR-loaded lipid-polymer hybrid nanoparticles(Zhao et al., 2014).",
      "startOffset" : 136,
      "endOffset" : 155
    }, {
      "referenceID" : 45,
      "context" : "Previous studies on GO-conjugated PEG for drug delivery have improved efficacy of paclitaxel against breast adenocarcinoma (MCF-7), non-small cell lung cancer (A549) and prostate cancer (Thapa et al., 2016; Z. Xu et al., 2014).",
      "startOffset" : 186,
      "endOffset" : 226
    }, {
      "referenceID" : 26,
      "context" : "AS1411 can attach to nucleolin with high affinity and is then penetrated into the tumor cells, comprising in colorectal, breast, prostate, and NSCLC (Liao et al., 2015; Tang et al., 2015; Zhong, Meng, Deng, & Zhong, 2014).",
      "startOffset" : 149,
      "endOffset" : 221
    }, {
      "referenceID" : 44,
      "context" : "AS1411 can attach to nucleolin with high affinity and is then penetrated into the tumor cells, comprising in colorectal, breast, prostate, and NSCLC (Liao et al., 2015; Tang et al., 2015; Zhong, Meng, Deng, & Zhong, 2014).",
      "startOffset" : 149,
      "endOffset" : 221
    } ],
    "year" : 2016,
    "abstractText" : "In the current study, dextran (DEX) was covalently conjugated to the surface of nano-GO sheets, making stable biocompatible dextran coated GO (GO-DEX). The prepared GO-DEX was nontoxic to 4T1 mammary carcinoma cell line at concentrations up to 300 μg/mL. AS1411 aptamer, a ssDNA aptamer which can improve the intracellular uptake by nucleolin recognition, also has been introduced to hydroxyl groups of DEX in GO-DEX to produce GO-DEX-Apt. Moreover, curcumin (CUR), a natural polyphenol, found in the rhizomes of Curcuma longa (turmeric) which shows antineoplastic effects, was loaded onto the GO-DEX and GO-DEX-Apt via π-π stacking interactions with a high loading capacity (~ 29 wt%). The GO-DEX-Apt-CUR could efficiently enter into 4T1 and MCF-7 nucleolin over-expressed cancer cells confirmed by fluorescence microscope and flowcytometry, and it also showed significantly higher cytotoxicity. These types of targeted nanoscale drug delivery vehicles on the basis of DEX coated GO may find potential application in cancer chemotherapy.",
    "creator" : "Elsevier"
  }
}